"Private sightseeing facility may be arranged on request basis through travel desk at school of biochemical engineering"
Prof. Rama Shanker Verma is a Professor at the Department of Biotechnology, Indian Institute of Technology, Chennai. He is currently heading the Stem Cell and Molecular Biology Laboratory. Prof. Verma have also been associated with top pharmaceutical comoanies like Cadila Healthcare and Lupin Pharmaceuticals. His current area of research mainly includes Stem Cell Biology, Tissue Regeneration, Immuntoxin, and Folate Receptor studies.
Dr. Chenzhong Li is a full professor and the director of the Nanobioengineering / Bioelctronics Lab at the Department of Biomedical Engineering, Florida International University. He is also the program director of Biosensing program at National Science Foundation. Dr. Li is an expert in biomedical devices in particular for Point of Care Testings and cell/organ on a chip.
Prof. Dhirendra .S. Katti, is currently associated with Indian Institute of Technology, Kanpur. He received his PhD from University of Mumbai and then did his Post-Doctoral training from Drexel University, USA. At present his lab mainly focuses on research to develop biomaterial based technologies for controlled drug delivery and tissue engineering applications. The main research interests are:
Dr. Joshua Hutcheson is currently an Assistant Professor at the Florida International University. He did his PhD from the Department of Biomedical Engineering, Vanderbilt University and then his Post-Doctoral work from Harvard University Medical School. He currently heads the Cardiovascular Matrix Remodeling Laboratory and his current research interests include Cardiovascular disease and mechanobiology–Cellular mechanisms of disease Cell-cell and cell-matrix interactions–Cellular interactions in tissue homeostasis. Tissue engineering–Development of engineered tissue substitutes Molecular imaging–Imaging of cardiovascular tissue remodelling and disease.
Dr. Ranu Jung as the Wallace H. Coulter Eminent Scholars Chair of Biomedical Engineering and Chair of the Department of Biomedical Engineering starting in January 2011. Professor Jung is a leader in the rapidly expanding fields of Neural Engineering and Computational Neuroscience. r. Jung comes to FIU from Arizona State University where she is the Director of the Center for Adaptive Neural Systems
A multi-disciplinary center approved by the Arizona Board of Regents. She is a tenured faculty member of the School of Biological and Health Systems Engineering, and is affiliated with the School of Electrical and Energy Engineering and is also a member of the graduate faculty of the Neuroscience and Applied Mathematics doctoral degree programs. The prestigious "New Florida Scholar’s Boost Award", a Florida state program to attract nationally recognized faculty in health/engineering, has been recommended for Dr. Jung. She currently leads a Bioengineering Research Partnership that is funded through a multi-year award from the National Institutes of Health. With this partnership, she and her team are developing a novel, fully implanted neural interface between a myolectric prosthetic hand and peripheral nerves of below-the-elbow amputees.
Prof. Kaushal Rege is currently a Professor of Chemical Engineering at the Arizona State University. He did his PhD from the Rensselaer Polytechnic Institute and then his Post- Doctoral studies from Massachusetts General Hospital and Harvard Medical School, Boston. His current research interests include : Molecular and Nanoscale Bioengineering, Non-viral Gene Delivery, Synergistic (Combination) Cancer Treatments, Intracellular Trafficking of Nanoscale Cargo in Cancer Cells, Cancer Gene Therapy, Radiation Sensing and Treatment, Tissue Models of Cancer Diseases, Microfluidic Devices for Drug Screening, Biological Separations.
Prof. Virendra S. Bisaria is a retired Professor from the Indian Institute of Technology, Delhi. He did his PhD from IIT, Delhi in 1978. His Post –Doctoral research experience included from Institutes like: Institute of Biotechnology, Swiss Federal Institute of Technology, Zurich, Switzerland; Institute of Biotechnology, Nuclear Research Centre, Julich, Germany; University of Minnesota, Minneapolis, USA; Institute of Biotechnology, University of Cambridge, UK; International Centre for Biotechnology, Osaka University, Japan; Kobe University, Japan; Oak Ridge National Laboratory, Oak Ridge, TN, USA. His main area of research included Lignocellulose Bioconversion of renewable resources to value added products - cellulose hydrolysis, stabilization of cellulases, regulation of cellulase and xylanase biosynthesis; applications of cellulase and xylanase enzymes; Biofuels and Biorefinery - Ethanol from cellulose/hemicellulose; metabolic engineering for production of bioproducts such as 2,3-butanediol and malic acid in suitable bacterial hosts. Bioinoculants (biofertilizers and biopesticides); Plant Cell Technology - production of therapeutic compounds, metabolic engineering for enhanced production of metabolites.
Dr. Ashok Kumar is currently the President of the R&D at the IPCA Laboratories, Mumbai. He pursued his PhD from CRI, Lucknow and his Post –Doctoral studies from University of Sussex, UK. In 2000, he joined IPCA Labs. He was determined to implement a different strategy to accelerate IPCA’s R&D initiatives. Having seen IPCA grow from a 350-crore company to one clocking an annual turnover of over 2,500 crore, Dr Ashok Kumar, president- Center for Research and Development, IPCA Labs, is now leaving no stone unturned to exploit the biotech and drug discovery space. In the last few years, IPCA’s R&D team has brought out over 100 products. Apart from organic chemistry, Dr Kumar is currently aligning his attention to two promising but high risk segments – fermentation-based products and biosimilars.
Dr. Emilia Entcheva’s laboratory (the Cardiac Optogenetics & Optical Imaging Laboratory) combines biophotonics tools with human stem-cell-derived cardiomyocyte technology and gene editing approaches to aid the advancement of personalized medicine.
The lab’s work is funded by the National Science Foundation and the National Institutes of Health. For example, they recently, received a $2 million collaborative research award from the NSF’s Emergent Frontiers in Research and Innovation (EFRI) program to develop opto-epigenetic control tools for human heart cells, with MGH/Harvard, Georgia Tech and the Cancer Center at GW. Another recent collaborative project funded by a $2.8 million NIH award is to develop high-throughput all-optical technology for chronic monitoring and control of human stem-cell-derived heart cells. The lab combines optogenetics (the use of light for the precise interrogation and control of cells and tissues), on-demand oxygenation with perfluorocarbons, microfluidics, optical instrumentation and control, and transcriptomics analysis to help improve the maturity of engineered human heart tissues and their use in drug-screening applications.
Overall, their research relies on both experimental and computational approaches to define the biophysical limits of and develop the technological innovations needed for a fundamentally new highly-parallel framework for all-optical cardiac electrophysiology in vitro and in vivo. They use lab-on-a-chip platforms, single primary or stem-cell-derived cardiomyocytes and engineered tissues. They apply their technology to study cell-cell communication and control of spatiotemporal phenomena like cardiac arrhythmias, to improve cardiotoxicity testing and drug screening.
Dr. Nandita Das is currently a Professor in Pharmaceutics at Butler University. She did her B.S in Pharmacy and M.S. In Pharmaceutics from Banaras Hindu University, before pursing her PhD in Pharmaceutics from University of Pittsburgh, USA. Her current area of expertise includes Biopharmaceutics, drug targeting, anticancer drug delivery, multi-drug resistance and nanomedicine.
James Abbas is an associate professor and director of the Center for Adaptive Neural Systems in the School of Biological and Health Systems Engineering at Arizona State University. His research interests are in applications of neural engineering techniques and technology in the area of medical rehabilitation. Current projects include the development and assessment of systems that use electrical stimulation for therapy after spinal cord injury, systems to improve neuromotor control in children with cerebral palsy, systems to restore sensory capabilities to amputees, and techniques to improve sensorimotor function in people with Parkinson’s Disease. He received his bachelor's degree in bioelectrical engineering from Brown University in Providence, RI and his master's degree and doctorate in biomedical engineering from Case Western Reserve University in Cleveland, OH.
Dr. Bhatnagar brings a wealth of telecom experience to Aeris, including heading digital services for 10 years in Europe, five years in the Americas, and six years in India. Prior to joining Aeris, he was Global Head for Digital Enterprise Services at Tech Mahindra, where Dr. Bhatnagar spearheaded the Internet of Things initiatives for the company and smart city projects for the Mahindra Group. Along with a team from Bosch, he co-authored the book, Enterprise IoT, which covers IoT project management frameworks, and the methodology proposed in this book has been accepted by the Industrial Internet Consortium (IIC). Dr. Bhatnagar is the chairperson of the Institution of Engineering and Technology (IET), recognized in India as a meeting place for sector leaders to interact and support standards, policies, and innovation. He also is a member of the Nasscom Regional Council and the Core Group by the Confederation of Indian Industry, and he received the ‘Digitalist Thought-Leader’ Award in the Internet of Things category at the Digital Transformation Forum 2015 by SAP India. Dr. Bhatnagar holds a PhD in IT and Computer Science from Singhania University, Rajasthan, India.
Deepanwita Chattopadhyay, Chairman & CEO of IKP Knowledge Park (erstwhile ICICI Knowledge Park), is responsible for developing the first Life Science Research Park in India and establishing a sustainable innovation and knowledge cluster around a science park through a Public-Private Partnership model. She has deep interest in entrepreneurship, incubation and institution building. Apart from developing a commercially sustainable not-for-profit Science Park and Life Science Incubator, she pioneered an Engineering Design and Hardware Product Incubator and Makerspace to fuel the maker movement and culture of ‘making’ in India. Deepanwita works with several global and Indian partners from public and private sectors to nurture and fund over 150 healthcare product innovators and startups. She has been implementing a large number of Grand Challenges programmes in India. Deepanwita is the Founder Chairman of Support Elders Pvt. Ltd., a startup committed to providing integrated care for the elderly. She serves as the President of IKP EDEN and as a Director on the Board of IKP Investment Management Company Pvt. Ltd. She is a member of the Governing Body of the National Institute of Immunology, the Lucknow Biotech Park, NCR Biotech Science Cluster and the TiE Hyderabad Chapter, an Executive Council member of the Society for Technology Managers (STEM) and member of several committees including the DBT Committee of Biotech Parks & Incubators, CII National Committee on Biotechnology, Life Sciences Advisory Committee of the Government of Telangana and the Karnataka Startup Council. She served as an international Director on the Board of the International Association of Science Parks (IASP) from 2012 to 2014, as a Member of the Indo US Science & Technology Endowment Board and Co-Chair of the Health Panel from 2011 to 2015 and as a Member of the Wellcome Trust Affordable Healthcare Committee during 2013 to 2015.
The Indo-US Conference on Bioengineering and Regenerative Medicine (ICBR- 2020) will be held during Feb 27-29, 2020 at the School of Biochemical Engineering, IIT (BHU), Varanasi, India.
The conference aims at creating an effective platform for the exchange of innovative ideas and research in the field of Bioengineering and Regenerative Medicine to accomplish a healthy and sustainable economy. The thematic areas of the conference include important sessions from areas like Biopharmaceutical and Medical Biotechnology, Bioprocess and Bioseparation Engineering, Biochips, Biosensors, Biomaterials, Tissue Engineering, and Regenerative Medicine.
The primary objective of this conference is to increase bilateral cooperation in academic exchange and technology development in cutting edge science and have direct social relevance to humankind, especially in India. SPARC aims at improving the research ecosystem of India’s Higher Education Institutions by facilitating academic and research collaborations between Indian Institutions and the top global Institutions. It is the first international conference organized by the School of Biochemical Engineering, IIT (BHU), Varanasi which will enrich the Indo-US collaboration and promotion of bilateral cooperation through academic and research partnership between FIU, Miami, and IIT (BHU), Varanasi.
Special Sessions will be the part of the conference. This would involve Idea/ Start-up Conclave all along the conference days. The Idea/Start-up Conclave is planned for participation by students where registration should be made separately. The selection of students for contest will be made by the committee after precise considerations.
These awards will be given by an eminent jury on the basis of your paper submitted / presented and overall research achievement.
Varanasi, the oldest living city of the world and holiest city in Hinduism, is a cultural center of North India situated on the banks of river Ganga and is also known as the land of The Shiva. The city is known worldwide for its ghats, embankments made in steps of stone slabs along the river. Some of them being the Dashashwamedh Ghat, the Panchganga Ghat, the Manikarnika Ghat, and the Harishchandra Ghat where pilgrims perform rituals and can watch Ganga Aarti. Varanasi has grown to be an important industrial center, famous for its muslin and silk fabrics, perfumes, ivory works, and sculptures.
Varanasi has also remained a center of activity for intellectuals and theologians during the Middle Ages, which further contributed to its prestige as a cultural center of religion and education. Varanasi attracts students and scholars from across the country and has an overall literacy rate of 80%. It is home to several colleges and universities. The campus of Banaras Hindu University (BHU), which is one of the most prominent residential universities in Asia with over 20,000 students, is located in the heart of Varanasi. The Indian Institute of Technology (BHU) Varanasi is designated an Institute of National Importance and is one of the 23 Indian Institutes of Technology.